Diakonos Oncology Stock

Develops innovative cancer immunotherapy using proprietary dendritic cell platform targeting late-stage and aggressive cancers.

Buy

Buy Diakonos Oncology shares

Sign up to view historical trading trends and place an offer.

Sell

Sell Diakonos Oncology shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Overview

Diakonos Oncology is dedicated to revolutionizing cancer immunotherapy with its proprietary double-loaded, patient-derived dendritic cell therapeutic platform focused on addressing the critical, unmet medical need for treatment of late-state and aggressive cancers.

Founded

2022

Headquarters

Houston, TX

Buy

Buy Diakonos Oncology shares

Sign up to view historical trading trends and place an offer.

Sell

Sell Diakonos Oncology shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Investors

Major Diakonos Oncology investors

  • Baylor College of Medicine

Diakonos Oncology Valuations & Financials

Gain insights Into Diakonos Oncology Stock Valuation & Share Prices

View real-time NPM data on Diakonos Oncology stock including most recent valuation and historical share price information. Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.

Similar Companies

Explore companies

like Diakonos Oncology

FAQ

Questions?

We have answers

Buy Diakonos Oncology Stock

Diakonos Oncology stock does not trade on public stock exchanges. Diakonos Oncology stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Diakonos Oncology stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Diakonos Oncology Stock

Diakonos Oncology Stock does not trade on public stock exchanges. In order to sell Diakonos Oncology shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

Diakonos Oncology Stock Price

Diakonos Oncology does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Diakonos Oncology share price and other valuable private market data.

Read more about secondary market private company stock prices:

Diakonos Oncology Stock Ticker Symbol

There is no ticker symbol for Diakonos Oncology stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Diakonos Oncology Stock

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Diakonos Oncology stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in Diakonos Oncology Stock

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Diakonos Oncology stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Diakonos Oncology Stock Settlement

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Diakonos Oncology IPO

Diakonos Oncology is a private company and has not had an IPO. There is currently no Diakonos Oncology IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Diakonos Oncology IPO.

Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.